Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|December 20, 2011
Novel substituted pyrimidines as HCV replication (replicase) inhibitorsCecil D Kwong, Jeremy L Clark, Anita T Fowler, et al.Bioorganic & Medicinal Chemistry Letters|March 10, 2012
Discovery of oxazole-based PDE4 inhibitors with picomolar potencyRongze Kuang, Ho-Jane Shue, Li Xiao, et al.Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutionsHo-Jane Shue, Xiao Chen, John H Schwerdt, et al.Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitorsDavid B Belanger, Michael J Williams, Patrick J Curran, et al.Bioorganic & Medicinal Chemistry Letters|August 9, 2007
Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitorsRongze Kuang, Ho-Jane Shue, David J Blythin, et al.European Journal of Pharmacology|September 11, 2002
SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonistJohn C Anthes, Richard W Chapman, Christian Richard, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2005
Cyclic urea derivatives as potent NK1 selective antagonistsHo-Jane Shue, Xiao Chen, Neng-Yang Shih, et al.Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffoldWayne D Vaccaro, Rosy Sher, Michael Berlin, et al.Bioorganic & Medicinal Chemistry Letters|February 1, 2011
II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonistsYuefei Shao, Gopinadhan N Anilkumar, Carolyn Diianni Carroll, et al.Bioorganic & Medicinal Chemistry Letters|June 1, 2017
Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitorsLing Tong, Seong Heon Kim, Kristin Rosner, et al.Pageof 7